ResMed Inc. (RSMDF)
OTCMKTS
· Delayed Price · Currency is USD
25.67
0.00 (0.00%)
At close: Mar 5, 2026
ResMed Revenue
ResMed had revenue of $1.42B in the quarter ending December 31, 2025, with 10.98% growth. This brings the company's revenue in the last twelve months to $5.40B, up 9.57% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.
Revenue (ttm)
5.40B
Revenue Growth
+9.57%
P/S Ratio
6.79
Revenue / Employee
509.26K
Employees
10,600
Market Cap
36.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.15B | 461.03M | 9.84% |
| Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
| Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
| Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
| Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cardiac Biotech Solutions | 50.37K |
| Meihua International Medical Technologies | 89.55M |
| Reflect Scientific | 1.72M |
| Standard Dental Labs | 306.82K |
| Encision | 6.30M |
| Yubo International Biotech | -18.00 |
| Lancer Orthodontics | 6.19M |
| Hear AtLast Holdings | 93.20K |
ResMed News
- 4 days ago - Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach - GlobeNewsWire
- 10 days ago - ResMed At $250: Missed Opportunity Or A Trap In The Making? - Forbes
- 11 days ago - Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana - GlobeNewsWire
- 19 days ago - Invesco International Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 4 weeks ago - Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge - Reuters
- 5 weeks ago - ResMed: Facing A Potentially Dream-Disrupting Dose - Strong Sell - Seeking Alpha
- 5 weeks ago - Analysts Maintain Bull Case On ResMed Despite Competition Concerns - Benzinga
- 5 weeks ago - ResMed Inc. (RMD) Q2 2026 Earnings Call Transcript - Seeking Alpha